Relevant markers of immature or aberrant phenotypes include co-expression analysis of CD34, CD10, CD30, TdT, or CD5 in B-NHL, and CD34, CD10, CD30, TdT, or CD1a in suspected CNS involvement of peripheral T cell-NHL. This evidence concerns the gene MME and non-Hodgkin lymphoma.